Table 2 The impact and efficiency of alternative introduction strategies
Introduction of PCV via | IPD averted after 10 years | Doses administered | Incremental NVN | NVN |
|---|---|---|---|---|
Cohort only | 155 (121–193) | 204,671 | 1321 (1058–1698) | 1321 (1058–1698) |
+ U1 catch-up | 173 (134–216) | 218,089 | 757 (618–973) | 1263 (1012–1623) |
+ U2 catch-up | 189 (147–235) | 224,952 | 412 (296–606) | 1188 (958–1527) |
+ U5 catch-up | 220 (172–270) | 241,546 | 543 (403–763) | 1098 (894–1405) |